Skip to content

Klimop: a study on older cancer patients

Klimop: a study on older cancer patients - KLIMOP

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39462
Enrollment
2180
Registered
2011-02-14
Start date
2011-10-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer neoplasms

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: OLDER AND YOUNGER CANCER PATIENTS: - Consenting after being informed - aged 50 years and older at time of inclusion - Life expectancy more than 6 months (based on the judgement of the attending doctor) - Persons who have a thorough command of Dutch - Persons who live in the province of Limburg - Interview within three months after cancer diagnosis;OLDER PATIENTS WITHOUT CANCER: - Consenting after being informed - aged 70 years and older at time of inclusion - Life expectancy more than 6 months (based on the judgement of the attending doctor) - Persons who have a thorough command of Dutch - Persons who live in the province of Limburg;CENTRAL CAREGIVERS: - Consenting after being informed - Persons who have a thorough command of Dutch

Exclusion criteria

Exclusion criteria: OLDER AND YOUNGER CANCER PATIENTS: - Persons with a formal diagnosis of dementia - Persons with a previous diagnosis of invasive cancer (except non-melanoma of the skin) - Persons too ill to participate (based in the judgement of the attending doctor);OLDER PATIENTS WITHOUT CANCER: - Persons with a formal diagnosis of dementia - Persons with a previous diagnosis of invasive cancer (except non-melanoma of the skin) - Persons too ill to participate (based in the judgement of the attending doctor);CENTRAL CAREGIVERS: no exclusion criteria

Design outcomes

Primary

MeasureTime frame
Wellbeing.

Secondary

MeasureTime frame
Survival Caregiver's distress Treatment characteristics (Type of Treatment, Completion of therapy, Complications, Complaints (e.g. fatigue, pain), Hospitalizations)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)